164 results
Page 2 of 9
6-K
EX-99.2
gg0waw 5x5
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
65k4zeewqgl9 c32f
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.2
h30m6qj rmbrm
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
iec1 e9qduy4lnczdh9
28 Jul 22
Current report (foreign)
2:52pm
6-K
EX-99
ohk 6phh3y
26 Jul 22
Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing
1:45pm
6-K
EX-99.4
kod0h
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
x79uuakj6kp 1bvcv
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.4
9yxrbf29
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.3
qvygw1swxb22ksr
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.1
47am8ew
29 Mar 22
RepliCel Announces Non-brokered Private Placement
1:02pm
6-K
EX-99.1
o1lbv1 7i1
29 Mar 22
RepliCel Announces Material Patent Milestones
12:51pm
6-K
EX-99.2
poc8 3hq6t0y
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.3
p83uwym
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.2
l39wvoqai5fg9zxdn
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
8zkshb9q
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.1
idmehyz4
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.1
wdo34zyk7avr9u9ctkl
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.2
0sw9dm5 pbup00nmg
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.1
249zpu60
21 Oct 21
Current report (foreign)
3:49pm